Based on HSP70/NF-?B/Caspase3 signaling pathway to explore the clinical mechanism of Cangfu Daotan Prescription in patients with phlegm-dampness polycystic ovary syndrome
- Conditions
- Polycystic ovary syndrome
- Registration Number
- ITMCTR2200005785
- Lead Sponsor
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
? It conforms to the diagnostic criteria of traditional Chinese and Western medicine
? Body mass index (BMI) was greater than 25kg/m2
?20= age =35 years
? No hormone drugs were used in the first three months of treatment
? Sign relevant informed consent
? Approved by the Ethics Committee
? In line with the Human Assisted Reproductive Technology Specifications
? Those who do not follow the doctor's advice or are allergic to the Chinese medicine ingredients
? Complicated with endometriosis, adenomyosis, ovarian tumor, decreased ovarian reserve function, pelvic inflammatory disease and other systemic diseases affecting ovarian function
? Infertility caused by genetic factors
(4) a history of recurrent abortion
? Abnormal anatomical structure of female reproductive tract does not have pregnancy function
? The woman suffers from serious physical or mental disease and cannot bear pregnancy
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method I?Ba;NF-?B;Heat shock protein 70;Caspase-3;
- Secondary Outcome Measures
Name Time Method Clinical pregnancy rate;Optimal rate of embryo;Ratio of the egg;A number of eggs;